CAD 0.07
(0.0%)
Year | Revenue | Revenue Growth |
---|---|---|
2023 | 115.95 Million CAD | 46.18% |
2022 | 79.32 Million CAD | 51.23% |
2021 | 52.45 Million CAD | 75.25% |
2020 | 29.93 Million CAD | 380.03% |
2019 | 6.23 Million CAD | 0.0% |
2018 | - CAD | 0.0% |
2017 | - CAD | 0.0% |
2016 | - CAD | 0.0% |
2015 | - CAD | 0.0% |
2014 | - CAD | 0.0% |
2013 | - CAD | 0.0% |
2012 | - CAD | 0.0% |
2011 | - CAD | 0.0% |
2010 | - CAD | 0.0% |
2009 | - CAD | 0.0% |
2008 | - CAD | 0.0% |
2007 | - CAD | 0.0% |
2006 | - CAD | 0.0% |
2005 | - CAD | 0.0% |
2004 | - CAD | 0.0% |
2003 | - CAD | 0.0% |
2002 | - CAD | 0.0% |
2001 | - CAD | 0.0% |
2000 | - CAD | 0.0% |
1999 | - CAD | 0.0% |
1998 | - CAD | 0.0% |
Year | Revenue | Revenue Growth |
---|---|---|
2024 Q1 | 20.95 Million CAD | -24.45% |
2024 Q2 | 22.16 Million CAD | 5.77% |
2023 Q2 | 30.89 Million CAD | 13.83% |
2023 Q4 | 27.73 Million CAD | -8.14% |
2023 Q3 | 30.19 Million CAD | -2.28% |
2023 FY | 115.95 Million CAD | 46.18% |
2023 Q1 | 27.14 Million CAD | 5.21% |
2022 Q1 | 16.65 Million CAD | 18.78% |
2022 Q3 | 18.32 Million CAD | -1.26% |
2022 Q4 | 25.79 Million CAD | 40.8% |
2022 FY | 79.32 Million CAD | 51.23% |
2022 Q2 | 18.55 Million CAD | 11.45% |
2021 Q1 | 12.62 Million CAD | 10.51% |
2021 Q4 | 14.01 Million CAD | 4.85% |
2021 FY | 52.45 Million CAD | 75.25% |
2021 Q3 | 13.36 Million CAD | 7.47% |
2021 Q2 | 12.44 Million CAD | -1.47% |
2020 Q3 | 7.57 Million CAD | 28.64% |
2020 FY | 29.93 Million CAD | 380.03% |
2020 Q4 | 11.42 Million CAD | 50.77% |
2020 Q1 | 5.03 Million CAD | 40.36% |
2020 Q2 | 5.89 Million CAD | 16.98% |
2019 Q3 | 1.66 Million CAD | 81.93% |
2019 Q1 | 73 Thousand CAD | 0.0% |
2019 Q2 | 913 Thousand CAD | 1150.68% |
2019 FY | 6.23 Million CAD | 0.0% |
2019 Q4 | 3.58 Million CAD | 116.01% |
2018 Q1 | - CAD | 0.0% |
2018 FY | - CAD | 0.0% |
2018 Q2 | - CAD | 0.0% |
2018 Q3 | - CAD | 0.0% |
2017 Q1 | - CAD | 0.0% |
2017 FY | - CAD | 0.0% |
2017 Q4 | - CAD | 0.0% |
2017 Q3 | - CAD | 0.0% |
2017 Q2 | - CAD | 0.0% |
2016 Q3 | - CAD | 0.0% |
2016 Q4 | - CAD | 0.0% |
2016 FY | - CAD | 0.0% |
2016 Q1 | - CAD | 0.0% |
2016 Q2 | - CAD | 0.0% |
2015 Q1 | - CAD | 0.0% |
2015 FY | - CAD | 0.0% |
2015 Q3 | - CAD | 0.0% |
2015 Q4 | - CAD | 0.0% |
2015 Q2 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q1 | - CAD | 0.0% |
2014 Q4 | - CAD | 0.0% |
2014 FY | - CAD | 0.0% |
2013 Q4 | - CAD | 0.0% |
2013 FY | - CAD | 0.0% |
2013 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 Q1 | - CAD | 0.0% |
2012 Q3 | - CAD | 0.0% |
2012 Q1 | - CAD | 0.0% |
2012 FY | - CAD | 0.0% |
2012 Q4 | - CAD | 0.0% |
2012 Q2 | - CAD | 0.0% |
2011 FY | - CAD | 0.0% |
2011 Q4 | - CAD | 0.0% |
2011 Q3 | - CAD | 0.0% |
2011 Q2 | - CAD | 0.0% |
2011 Q1 | - CAD | 0.0% |
2010 Q4 | - CAD | 0.0% |
2010 Q3 | - CAD | 0.0% |
2010 FY | - CAD | 0.0% |
2010 Q2 | - CAD | 0.0% |
2010 Q1 | - CAD | 0.0% |
2009 Q3 | - CAD | 0.0% |
2009 FY | - CAD | 0.0% |
2009 Q4 | - CAD | 0.0% |
2009 Q2 | - CAD | 0.0% |
2009 Q1 | - CAD | 0.0% |
2008 FY | - CAD | 0.0% |
2008 Q1 | - CAD | 0.0% |
2008 Q2 | - CAD | 0.0% |
2008 Q3 | - CAD | 0.0% |
2008 Q4 | - CAD | 0.0% |
2007 Q3 | - CAD | 0.0% |
2007 Q4 | - CAD | 0.0% |
2007 Q2 | - CAD | 0.0% |
2007 Q1 | - CAD | 0.0% |
2007 FY | - CAD | 0.0% |
2006 Q2 | - CAD | 0.0% |
2006 Q3 | - CAD | 0.0% |
2006 Q1 | - CAD | 0.0% |
2006 FY | - CAD | 0.0% |
2006 Q4 | - CAD | 0.0% |
2005 Q4 | - CAD | 0.0% |
2005 Q1 | - CAD | 0.0% |
2005 Q3 | - CAD | 0.0% |
2005 Q2 | - CAD | 0.0% |
2005 FY | - CAD | 0.0% |
2004 Q2 | - CAD | 0.0% |
2004 Q4 | - CAD | 0.0% |
2004 Q3 | - CAD | 0.0% |
2004 FY | - CAD | 0.0% |
2004 Q1 | - CAD | 0.0% |
2003 Q3 | - CAD | 0.0% |
2003 FY | - CAD | 0.0% |
2003 Q4 | - CAD | 0.0% |
2003 Q1 | - CAD | 0.0% |
2003 Q2 | - CAD | 0.0% |
2002 Q4 | - CAD | 0.0% |
2002 Q3 | - CAD | 0.0% |
2002 Q1 | - CAD | 0.0% |
2002 FY | - CAD | 0.0% |
2002 Q2 | - CAD | 0.0% |
2001 Q4 | - CAD | 0.0% |
2001 Q3 | - CAD | 0.0% |
2001 Q2 | - CAD | 0.0% |
2001 Q1 | - CAD | 0.0% |
2001 FY | - CAD | 0.0% |
2000 FY | - CAD | 0.0% |
2000 Q2 | - CAD | 0.0% |
2000 Q3 | - CAD | 0.0% |
2000 Q1 | - CAD | 0.0% |
1999 FY | - CAD | 0.0% |
1999 Q3 | - CAD | 0.0% |
1998 FY | - CAD | 0.0% |
1998 Q3 | - CAD | 0.0% |
Name | Revenue | Revenue Difference |
---|---|---|
Aequus Pharmaceuticals Inc. | 254.89 Thousand CAD | -45392.279% |
CanadaBis Capital Inc. | 22.22 Million CAD | -421.806% |
Delivra Health Brands Inc. | 12.37 Million CAD | -836.807% |
Entourage Health Corp. | 40.71 Million CAD | -184.818% |
Lifeist Wellness Inc. | 21.65 Million CAD | -435.36% |
Cannara Biotech Inc. | 57.26 Million CAD | -102.511% |
Medicure Inc. | 21.69 Million CAD | -434.516% |
PharmaCielo Ltd. | 1.54 Million CAD | -7421.198% |
Rubicon Organics Inc. | 40.11 Million CAD | -189.053% |
BioSyent Inc. | 31.59 Million CAD | -267.068% |
Voyageur Pharmaceuticals Ltd. | - CAD | -Infinity% |